AOSLO Imaging for the Study of Cellular Alterations in Retinal Neurodegeneration

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age10-79
SponsorCentre Hospitalier National d'Ophtalmologie des Quinze-Vingts

About this trial

Primary objective:

\- Acquisition and analysis of images for non-medical purposes using the MONA IV system, an adaptive-optics-corrected scanning ophthalmoscope.

Secondary objectives:

* To measure the reproducibility of assessments; * To evaluate the detection of progressive changes.

Eligibility criteria

Qualifiers

100 subjects aged 10 to 79 years with a condition that may affect the inner retina (e.g., glaucoma, optic neuropathy, etc.)

100 subjects aged 10 to 80 years with a condition that may affect the outer retina (e.g., AMD, retinitis pigmentosa, etc.)

Male or female

Covered by health insurance

Disqualifiers

Inability to remain motionless on a standard ophthalmic chin rest. RETION_Protocol_v2.0 dated June 10, 2026_IDRCB: 2026-A00324-47 Page 10 of 44

Subjects taking medications or suffering from a medical condition that could interfere with the evaluations planned under the protocol;

Participants allergic to tropicamide in cases where pupil dilation is required. ☞ Wearing glasses or contact lenses to correct a refractive error is not considered an exclusion criterion.

Trial design

Treatments tested in this trial

  • MONA Imaging System

Treatment groups

260 Participants
are divided into 1 treatment group

Locations

This trial has no locations